Circulating microRNAs, novel biomarkers of acute myocardial infarction: a systemic review

doi:10.5847/wjem.j.issn.1920-8642.2012.04.003

Abstract

Abstract:

BACKGROUND: MicroRNAs (MiRNA) are a novel class of non-coding RNAs involved in the regulation of gene expression post-transcriptionally by cleavage or translational repression of their specific target miRNAs. Numerous studies have demonstrated that circulating miRNAs are stable and abundant in blood and aberrantly expressed under pathological conditions, including cardiovascular diseases. The implications of circulating miRNAs in acute myocardial infarction have recently been recognized. This review will highlight the potential role of miRNA as a novel class of biomarkers in acute myocardial infarction.

METHODS: This systemic review is based on our own work and other related reports.

RESULTS: During diseases circulating miRNAs are derived from not only circulating blood cells but also other tissues affected by ongoing diseases. These disease-related miRNAs in the blood can serve as potential biomarkers.

CONCLUSION: The circulating miRNAs can be used as novel biomarkers potentially offering more sensitive and specific tests than those currently available for diagnosis of acute myocardial infarction.

Key words: MicroRNAs, Acute myocardial infarction, Biomarkers

Yan Chen, Wei Yang, Gan-nan Wang, Jun Li, Xiao-rong Li, Jian Zhang, Wei Yuan, Dao-wu Wang, Jin-song Zhang, Ke-jiang Cao. Circulating microRNAs, novel biomarkers of acute myocardial infarction: a systemic review[J]. World Journal of Emergency Medicine, 2012, 3(4): 257-260.

References 38

1	Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA. et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009; 361:2538-2547. doi: 10.1056/NEJMoa0805299 pmid: 19940289
2	Swarup V, Rajeswari MR. Circulating (cell-free) nucleic acids-a promisingnon-invasive tool for early detection of several human diseases. FEBS Lett 2007; 581:795-799. doi: 10.1016/j.febslet.2007.01.051 pmid: 17289032
3	Tsang JC, Lo YM. Circulating nucleic acids in plasma/serum. Pathology 2007; 39:197-207. doi: 10.1080/00313020701230831 pmid: 17454749
4	Bartel DP. MicroRNAs: genomics biogenesis mechanism and function. Cell 2004; 116:281-297. doi: 10.1016/s0092-8674(04)00045-5 pmid: 14744438
5	van Rooij E, Marshall WS, Olson EN. Toward microRNA-based therapeutics for heart disease: the sense in antisense. Circ Res 2008; 103:919-928. doi: 10.1161/CIRCRESAHA.108.183426 pmid: 18948630
6	Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K. et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Research 2008; 18:997-1006. doi: 10.1038/cr.2008.282 pmid: 18766170
7	Lee Y, Jeon K, Lee JT, Kim S, Kim VN. MicroRNA maturation: stepwise processing and subcellular localization. Embo J 2002; 21:4663-4670. doi: 10.1093/emboj/cdf476 pmid: 12198168
8	Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J. et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003; 425:415-419. doi: 10.1038/nature01957 pmid: 14508493
9	Kim VN. MicroRNA precursors in motion: exportin-5 mediates their nuclear export. Trends Cell Biol 2004; 14:156-159. doi: 10.1016/j.tcb.2004.02.006
10	Zeng Y, Cullen BR. Structural requirements for pre-microRNA binding and nuclear export by Exportin 5. Nucleic Acids Res 2004; 32:4776-4785. doi: 10.1093/nar/gkh824 pmid: 15356295
11	Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E. et al. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005; 120:21-24. doi: 10.1016/j.cell.2004.12.031 pmid: 15652478
12	Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K. et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008; 141:672-675. doi: 10.1111/j.1365-2141.2008.07077.x pmid: 18318758
13	Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K. et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18:997-1006. doi: 10.1038/cr.2008.282 pmid: 18766170
14	Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105:10513-10518. pmid: 18663219
15	Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N. et al. Serum microRNAs are promising novel biomarkers. PLoS ONE 2008; 3:e3148. doi: 10.1371/journal.pone.0003148 pmid: 18773077
16	Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N. et al. Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 2009; 55:1944-1949. doi: 10.1373/clinchem.2009.125310 pmid: 19696117
17	Hyun TK, Uddin MN, Rim Y, Kim JY. Cell-to-cell trafficking of RNA and RNA silencing through plasmodesmata. Protoplasma 2011; 248:101-116. doi: 10.1007/s00709-010-0225-6
18	Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N. et al. Serum microRNAs are promising novel biomarkers. PLoS ONE 2008; 3:e3148. doi: 10.1371/journal.pone.0003148 pmid: 18773077
19	Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010; 107:1047-1057. doi: 10.1161/CIRCRESAHA.110.226456 pmid: 21030722
20	Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9:654-659. doi: 10.1038/ncb1596 pmid: 17486113
21	Darnell DK, Kaur S, Stanislaw S. MicroRNA expression during chick embryo development. Dev Dyn 2006; 235:3156-3165. doi: 10.1002/dvdy.20956 pmid: 17013880
22	Vrijsen KR, Sluijter JP, Schuchardt MW, van Balkom BW, Noort WA, Chamuleau SA. et al. Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells. J Cell Mol Med 2010; 14:1064-1070. doi: 10.1111/j.1582-4934.2010.01081.x pmid: 20465578
23	Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M. et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008; 10:1470-1476. doi: 10.1038/ncb1800 pmid: 19011622
24	Feng Y, Yu X. Cardinal roles of miRNA in cardiac development and disease. Sci China Life Sci 2011; 54:1113-1120. doi: 10.1007/s11427-011-4257-8 pmid: 22227903
25	Da CMP, Salic K, Gladka MM. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol 2010; 12:1220-1227. doi: 10.1038/ncb2126 pmid: 21102440
26	Ren XP, Wu J, Wang X. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 2009; 119:2357-2366. doi: 10.1161/CIRCULATIONAHA.108.814145 pmid: 19380620
27	Zhang X, Wang X, Zhu H. Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death. J Mol Cell Cardiol 2010; 49:841-850. doi: 10.1016/j.yjmcc.2010.08.007
28	Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74:1124-1136. doi: 10.1161/01.cir.74.5.1124 pmid: 3769170
29	Rane S, He M, Sayed D, Vashistha H, Malhotra A, Sadoshima J. et al. Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res 2009; 104:879-886. doi: 10.1161/CIRCRESAHA.108.193102 pmid: 19265035
30	Qian L, Van Laake LW. Huang Y. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J Exp Med 2011; 208:549-560. doi: 10.1084/jem.20101547
31	Yang B, Lin H, Xiao J. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007; 13:486-491. doi: 10.1038/nm1569 pmid: 17401374
32	Lu Y, Zhang Y, Wang N, Pan Z, Gao X, Zhang F. et al. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation 2010; 122:2378-2387. doi: 10.1161/CIRCULATIONAHA.110.958967 pmid: 21098446
33	van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, Richardson JA. et al. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 2009; 17:662-673. doi: 10.1016/j.devcel.2009.10.013 pmid: 19922871
34	Fichtlscherer S, De Rosa S, Fox HS, Shwietz T, Fischer A, Liebetrau C. et al. Circulating micro-RNAs in patients with coronary artery disease. Circ Res 2010; 107:677-684. doi: 10.1161/CIRCRESAHA.109.215566 pmid: 20595655
35	Devaux Y, Vausort M, Goretti E, Nazarov PV, Azuaje F, Gilson G. et al. Use of Circulating MicroRNAs to Diagnose Acute Myocardial Infarction. Clin Chem 2012; 58:559-567.Epub 2012 Jan 17. doi: 10.1373/clinchem.2011.173823 pmid: 22252325
36	Wang R, Li N, Zhang Y, Ran Y, Pu J. Circulating MicroRNAs are promising novel biomarkers of acute myocardial infarction. Intern Med 2011; 50:1789-1795. doi: 10.2169/internalmedicine.50.5129 pmid: 21881276
37	Kuwabara Y, Ono K, Horie T, Nishi H, Nagao K, Kinoshita M. et al. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate the existence of myocardial damage. Circ Cardiovasc Genet 2011; 4:446-454. doi: 10.1161/CIRCGENETICS.110.958975 pmid: 21642241
38	Meder B, Keller A, Vogel B, Haas J, Sedaghat-Hamedani F, Kayvanpour E. et al. MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Res Cardiol 2011; 106:13-23. doi: 10.1007/s00395-010-0123-2

[1]	Wan-qin Xie, Lin Zhou, Yong Chen, Bin Ni. Circulating microRNAs as potential biomarkers for diagnosis of congenital heart defects [J]. World Journal of Emergency Medicine, 2016, 7(2): 85-89.
[2]	Li-ming Li, Wen-bo Cai, Qin Ye, Jian-min Liu, Xin Li, Xiao-xing Liao. Comparison of plasma microRNA-1 and cardiac troponin T in early diagnosis of patients with acute myocardial infarction [J]. World Journal of Emergency Medicine, 2014, 5(3): 182-186.
[3]	Hua Zhou, Xiao-yan He, Shao-wei Zhuang, Juan Wang, Yan Lai, Wei-gang Qi, Yi-an Yao, Xue-bo Liu. Clinical and procedural predictors of no-reflow in patients with acute myocardial infarction after primary percutaneous coronary intervention [J]. World Journal of Emergency Medicine, 2014, 5(2): 96-102.
[4]	Li-li Ji, Xiao-feng Long, Hui Tian, Yu-fei Liu. Effect of transplantation of bone marrow stem cells on myocardial infarction size in a rabbit model [J]. World Journal of Emergency Medicine, 2013, 4(4): 304-310.
[5]	Xiao-dong Liu, Chun-lei Sun, Su-ping Mu, Xiao-mei Qiu, Hai-ying Yu. Acute myocardial infarction in a child with myocardial bridge [J]. World Journal of Emergency Medicine, 2011, 2(1): 70-72.
[6]	Yu Chen, Zhi-jian Chen, Yu-hua Liao, Zhe Cao, Jia-ding Xia, Hua Yang, Yi-mei Du. Effect of tumor necrosis factor-α on ventricular arrhythmias in rats with acute myocardial infarction in vivo [J]. World Journal of Emergency Medicine, 2010, 1(1): 53-58.